Europe • Euronext Oslo • OSL:LIFE • NO0013355859
The current stock price of LIFE.OL is 0.455 NOK. In the past month the price decreased by -56.25%. In the past year, price decreased by -96.67%.
ChartMill assigns a fundamental rating of 2 / 10 to LIFE.OL. LIFE.OL may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months LIFE.OL reported a non-GAAP Earnings per Share(EPS) of -3.52. The EPS decreased by -40.54% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -144.73% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
null analysts have analysed LIFE.OL and the average price target is 36.72 NOK. This implies a price increase of 7970.33% is expected in the next year compared to the current price of 0.455.
For the next year, analysts expect an EPS growth of 8.12% and a revenue growth -75% for LIFE.OL
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 2M6 | MEDTRONIC PLC | 16.91 | 113.535B | ||
| 1MDT | MEDTRONIC PLC | 16.13 | 108.304B | ||
| SHL | SIEMENS HEALTHINEERS AG | 18.04 | 47.545B | ||
| 1PHIA | KONINKLIJKE PHILIPS NV | 16.27 | 23.842B | ||
| PHI1 | KONINKLIJKE PHILIPS NV | 16.19 | 23.717B | ||
| PHIA | KONINKLIJKE PHILIPS NV | 16.11 | 23.678B | ||
| BIM | BIOMERIEUX | 19.38 | 11.522B | ||
| DIA | DIASORIN SPA | 18.06 | 4.158B | ||
| OBCK | OTTOBOCK SE & CO KGAA | 19.83 | 3.916B | ||
| 1AFX | CARL ZEISS MEDITEC AG - BR | 14.5 | 2.513B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Oslo Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
Lifecare ASA engages in the research, testing, and development of medical sensors for health monitoring. The company is headquartered in Bergen, Hordaland and currently employs 28 full-time employees. The company went IPO on 2018-07-10. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.
LIFECARE ASA
Ytrebygdsvegen 215
Bergen HORDALAND NO
Employees: 32
Phone: 4740059040
Lifecare ASA engages in the research, testing, and development of medical sensors for health monitoring. The company is headquartered in Bergen, Hordaland and currently employs 28 full-time employees. The company went IPO on 2018-07-10. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.
The current stock price of LIFE.OL is 0.455 NOK. The price decreased by -4.61% in the last trading session.
LIFE.OL does not pay a dividend.
LIFE.OL has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
LIFECARE ASA (LIFE.OL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.52).
You can find the ownership structure of LIFECARE ASA (LIFE.OL) on the Ownership tab.